Kengrexal 50 mg powder for concentrate for solution for injection/infusion, Brilique 90 mg film-coated tablets clinical trials

PhARMacodynamics of earlY versus Delayed Administration of TIcagrelor during CAngrelor infusion in patients with acute ST-segment elevation Myocardial Infarction: a randomized superiority study

This study compares when to give a key heart medication (ticagrelor) after another (cangrelor) in people having a heart attack. We're checking if giving it earlier helps prevent blood clots better, and looking at important heart events and bleeding.